Trials / Completed
CompletedNCT04407494
Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19)
Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders in a Population Tested for COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 809 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Participants are healthcare workers and adult outpatients referred in a COVID-19 screening center. Patients-reported symptoms are collected, then participants underwent a simple olfactory test (CODA for Clinical Olfactory Dysfunction Assessment), prior to swabbing for SARS-CoV-2 diagnosis (RT-PCR). We aimed to evaluate the prevalence of smell and taste disorders, and to calculate the diagnostic value of patient-reported and clinically verified smell disorders in persons with suspected COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Reporting of anosmia, ageusia and other clinical symptoms | Reporting of anosmia, ageusia and other clinical symptoms related to COVID-19 - CODA test - SARS-CoV2 RT-PCR and ELISA |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2020-04-01
- Completion
- 2020-04-30
- First posted
- 2020-05-29
- Last updated
- 2020-06-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04407494. Inclusion in this directory is not an endorsement.